QTTB

NASD Q32 Bio Inc

Oct 7, 2026 · 8:48 PM ET LAST TRADE Market Closed

$7.91 ↓ -0.08 (-1.00%) Trading Down from the previous close of $7.99, $0.16 below the day’s high of $8.07

YTD change: +138.25%
vs 20-day SMA: -19.29%
vs 200-day SMA: -9.89%

Price ranges

Previous day

$7.80 $8.36

open $8.32 close $8.11

-$0.21 (-2.52%)

Today

$7.83 $8.07

open $8.00 now $7.91

-$0.09 (-1.12%)

Past week

$7.75 $10.40

from $9.53 now $7.91

-$1.62 (-17.00%)

Past month

$7.75 $11.95

from $11.69 now $7.91

-$3.78 (-32.34%)

This year

$3.19 $23.57

from $3.32 now $7.91

+$4.59 (+138.25%)

Price & Performance

+2.09 (+35.42%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 85.3% away from all-time highs of $53.79
QTTB is up 138% since the beginning of the year
QTTB is up 214% over the past 12 months
QTTB is down 32% over the past 1 month
13% of all QTTB investors are betting against QTTB

QTTB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +217.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.44

Earnings momentum -32.6% Quarterly EPS growth

Quarterly change -32.6%

Valuation

P/E ratio 2.67

Enterprise value $64.0M

Beta -0.57

Balance sheet & scale

Income$33.8K

Revenue$53.7M

Cash$106.3M

Debt$5.3K

Income / Debt 6.38×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $275.3M

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David S. Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.